Study to Evaluate the Pharmacokinetics of Tezepelumab in Children with Asthma

Trial Identifier: D5180C00025
Sponsor: AstraZeneca
NCTID:: NCT04673630
Start Date: February 2021
Primary Completion Date: September 2022
Study Completion Date: September 2022
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Afrikaans Translation
English Translation
English (South Africa) Translation
Hungarian Translation
Xhosa Translation

Trial Locations

Country Location
GB Bristol, GB, BS2 8BJ
GB Glasgow, GB, G51 4TF
GB London, GB, E1 1BB
GB London, GB, SE5 9RS
HU Budapest, HU, 1094
ZA Cape Town, ZA, 7700